Stocky turns companies like NRC Health into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.
Try Stocky free →Cautious. NRC shows balanced value fundamentals (54/100 Value Compounder Score) and solid leadership alignment (72.5/100, likely reflecting founder or insider ownership), but growth momentum is sluggish at 43.2/100 and healthcare revenue concentration limits diversification upside. At 23.4x forward earnings, valuation is fair but offers limited margin of safety given execution dependence.
Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for NRC Health:
Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 46/100, you know instantly whether to dig deeper or skip.
Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.
Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.
Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.
Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.
Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.
Stocky rates NRC Health (NRC) at 46/100 — below the bar Stocky looks for. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Cautious. NRC shows balanced value fundamentals (54/100 Value Compounder Score) and solid leadership alignment (72.5/100, likely reflecting founder or insider ownership), but growth momentum is sluggish at 43.2/100 and healthcare revenue co
NRC's current Stocky Verdict is 46/100, placing it in the "Cautious" band. This composite combines a 54/100 Compounder score, 73/100 Leadership, Moat rating, and analyst signal.
Stocky hasn't finalised a Moat Score for NRC Health yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.
NRC Health scores 73/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.
NRC Health's Vulnerability Profile scores 33/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to NRC Health.
Sign up free and unlock the full analysis on NRC — the same tools professional analysts use, personalised to your portfolio:
Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.
This page is just a preview. Open the live, interactive version for the full picture:
Or jump straight to the interactive dashboard for NRC in the app.
